NCT05777603 2026-04-09
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
Clinical Trials
12 trialsNCT02143466 2026-01-30
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
AstraZeneca
Phase 1 Active not recruiting
NCT04032847 2025-03-10
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
Achilles Therapeutics UK Limited
Phase 1/2 Terminated
NCT04886401 2025-02-06
PREDICTION
University Hospital, Brest
Recruiting
NCT06107374 2024-10-24
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
CellSight Technologies, Inc.
Phase 2 Recruiting
NCT06406166 2024-09-25
Lifei Xiaoji Wan in Treatment of Advanced NSCLC
Henan University of Traditional Chinese Medicine
Phase NA Recruiting
NCT04144608 2024-08-09
TOGATHER
Hunan Province Tumor Hospital
Phase 2 Completed
NCT05004974 2024-03-12
Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2 Unknown
NCT02407327 2023-11-01
2012/52
Istituto Oncologico Veneto IRCCS
Completed
NCT03452150 2023-04-25
D-0316 First Time in Patients Ascending Dose Study
InventisBio Co., Ltd
Phase 1 Completed
NCT03351361 2023-03-01
eNERGY
Rennes University Hospital
Phase 3 Completed
NCT03652857 2020-02-17
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2 Completed